Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02359019
Title Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

lung small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Medical Center Chicago Illinois 60612 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field